Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Globus Medical (GMED)
NYSE:GMED
Globus Medical (GMED) Stock Price & Analysis
758 Followers
GMED Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$43.39 - $73.89
Previous Close$72.63
Volume699.73K
Average Volume (3M)1.03M
Market Cap
$9.81B
Enterprise Value$10.28B
Total Cash (Recent Filing)$50.50M
Total Debt (Recent Filing)$520.40M
Price to Earnings (P/E)115.1
Beta1.29
Next Earnings
Aug 06, 2024EPS Estimate
$0.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.63
Shares Outstanding135,057,360
10 Day Avg. Volume1,066,122
30 Day Avg. Volume1,033,962
Standard Deviation0.10
R-Squared0.35
Alpha-0.00010
Financial Highlights & Ratios
Price to Book (P/B)5.48
Price to Sales (P/S)14.57
Price to Cash Flow (P/CF)21.50
P/FCF Ratio27.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.55
Enterprise Value/Gross Profit10.07
Enterprise Value/Ebitda32.74
Forecast
1Y Price Target
$72.90Price Target Upside-0.72% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Globus Medical News
PremiumCompany Announcements
Globus Medical Shareholders Approve Key Governance Changes
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTotal revenues hit $606.7 mln ahead of the Street's $586.8 mln.
Market ShareWeak spine numbers from competitor Johnson and Johnson suggest further competitive pressures in the segment, which is seen as a possible opportunity for GMED to take market share.
Regulatory ApprovalsGMED announced it had recently received 510(K) clearance of its ExcelsiusFlex robot navigation platform for a total knee arthroplasty application as well as its ACTIFY 3D Total Knee System for cement and cementless use.
Bears Say
Product LaunchThe robot will likely be soft launched at first and will most likely not contribute meaningfully to revenues in 2024.
Revenue GuidanceThere is concern whether GMED can achieve its 2024 sales guidance of $2,450-2,475 million.
Sales DisruptionThere is still potential risk of sales disruption from the integration.
---
Ownership Overview
14.42% Insiders
38.59% Mutual Funds
23.48% Other Institutional Investors
23.50% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GMED FAQ
What was Globus Medical’s price range in the past 12 months?
Globus Medical lowest stock price was $43.38 and its highest was $73.89 in the past 12 months.
What is Globus Medical’s market cap?
Currently, no data Available
When is Globus Medical’s upcoming earnings report date?
Globus Medical’s upcoming earnings report date is Aug 06, 2024 which is in 15 days.
How were Globus Medical’s earnings last quarter?
Globus Medical released its earnings results on May 07, 2024. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.567 by $0.153.
Is Globus Medical overvalued?
According to Wall Street analysts Globus Medical’s price is currently Overvalued.
Does Globus Medical pay dividends?
Globus Medical does not currently pay dividends.
What is Globus Medical’s EPS estimate?
Globus Medical’s EPS estimate is $0.68.
How many shares outstanding does Globus Medical have?
Globus Medical has 112,624,820 shares outstanding.
What happened to Globus Medical’s price movement after its last earnings report?
Globus Medical reported an EPS of $0.72 in its last earnings report, beating expectations of $0.567. Following the earnings report the stock price went up 20.191%.
Which hedge fund is a major shareholder of Globus Medical?
Among the largest hedge funds holding Globus Medical’s share is Fisher Asset Management LLC. It holds Globus Medical’s shares valued at 21M.
---
Globus Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$72.90 (-0.72% Downside)
$72.90 (-0.72% Downside)
Blogger Sentiment
Bullish
GMED Sentiment 66%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 81.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $4.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.1%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.38%
12-Months-Change
Fundamentals
Return on Equity
2.28%
Trailing 12-Months
Asset Growth
129.98%
Trailing 12-Months
Company Description
Globus Medical
Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.
---
GMED Earnings Call
Q1 2024
0:00 / 0:00
---
GMED Net sales Breakdown
92.34% Musculoskeletal Solutions
7.66% Enabling Technologies
---
GMED Stock 12 Month Forecast
Average Price Target
$72.90
▼(-0.72% Downside)
Technical Analysis
Best Analysts Covering GMED
1 Year
1 Year Success Rate
21/27 ratings generated profit
1 Year Average Return
+19.28%
reiterated a buy rating 2 months ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 77.78% of your transactions generating a profit, with an average return of +19.28% per trade.
---